Synch advised Innovestor Life Science Fund and Hadean Ventures on the deal.Gesynta Pharma completed a SEK 304 million funding round. The SEK 304 million secured in…
Gesynta Pharma’s Investment Round
Synch advised Innovestor Life Science Fund and Hadean Ventures on the deal.Gesynta Pharma completed a SEK 304 million funding round. The SEK 304 million secured in…